Enalapril Recall Injury Lawsuit Lawyers

Consumers Taking Recalled Enalapril Maleate Tablets May Face Risks Linked To Impurity And Degradation Issues

What Parker Waichman LLP Found

• Nationwide recall issued for Enalapril blood pressure medication
• Testing reportedly identified impurity or degradation concerns
• Recalled medications may expose consumers to unknown risks
• Blood pressure drug recalls involving contamination have increased in recent years
• Consumers harmed by recalled medications may have legal rights

A nationwide recall involving Enalapril Maleate Tablets has raised new concerns about the safety and quality of prescription medications used to treat hypertension and heart failure. The recalled medication was distributed throughout the United States after testing reportedly identified problems involving impurities or degradation within the product. The recall follows a growing pattern of blood pressure and heart medications being flagged for contamination concerns in recent years.

Consumers who rely on prescription medications expect those drugs to meet strict safety and quality standards. Patients taking blood pressure medications often use them daily for long periods of time to manage serious medical conditions. When quality issues emerge involving these medications, patients may face uncertainty, fear, and potential health risks.

The recalled medication was manufactured by Unique Pharmaceutical Laboratories, a division of JB Chemicals and Pharmaceuticals Ltd in India, and distributed in the United States by Rising Pharma Holdings, Inc. According to federal regulators, the recall involves Enalapril Maleate Tablets in 20-milligram dosages packaged in 1,000-count bottles.

Although federal regulators classified the recall as Class II, meaning the exposure is not likely to cause severe adverse health consequences in most situations, consumers may still have concerns about contamination, impurities, and long-term health risks. Medication recalls involving impurities often trigger legal scrutiny because patients may unknowingly consume compromised drugs for extended periods of time before the issue is identified.

Consumers who suffered injuries, medical complications, or emotional distress connected to recalled medications may have legal rights. Drug manufacturers and distributors have a responsibility to ensure medications meet safety and quality standards before reaching pharmacies and patients.

What Is Enalapril And Why Is It Prescribed?

Enalapril Maleate is a prescription medication commonly used to treat high blood pressure and heart failure. It belongs to a category of medications known as ACE inhibitors, which help relax blood vessels and reduce strain on the heart.

Doctors often prescribe Enalapril to help:

• Lower blood pressure
• Reduce the risk of stroke
• Improve heart function
• Treat congestive heart failure
• Reduce stress on blood vessels

Hypertension is one of the most common chronic medical conditions in the United States. Millions of Americans take medications like Enalapril every day to manage cardiovascular health. Because patients frequently rely on these medications long term, quality and manufacturing standards become critically important.

When contamination or degradation issues occur, patients may lose confidence in medications they depend upon to manage serious medical conditions. This concern becomes more significant when recalls involve potential impurities that may pose long-term health risks.

Why The Enalapril Medication Was Recalled

Federal regulators announced the recall after testing reportedly identified an issue involving impurities or degradation within the medication. According to regulatory reports, the recall was triggered after the product failed impurity and degradation specifications during routine testing.

The reported issue involved:

“Out of specification result occurred in Organic Impurities Test.”

This statement suggests the medication may have contained impurity levels exceeding acceptable standards. Although the specific impurity has not been publicly identified, recalls involving blood pressure medications have increasingly involved concerns about nitrosamines and other potentially harmful compounds.

Nitrosamines are chemical compounds that may develop during manufacturing, storage, or environmental exposure. Some nitrosamines are considered possible cancer-causing substances when exposure occurs over extended periods.

At this time, regulators have not publicly confirmed whether nitrosamines caused this specific recall. However, the broader history of recalls involving ACE inhibitors and contamination concerns has raised understandable consumer concern.

Growing Concerns About Nitrosamines In Blood Pressure Medications

In recent years, multiple blood pressure medications have been recalled due to contamination concerns involving nitrosamines. These recalls have affected medications used to treat hypertension, heart disease, and related cardiovascular conditions.

Nitrosamines may form unintentionally during manufacturing processes or as medications degrade over time. Environmental conditions, storage issues, packaging failures, or chemical interactions may contribute to contamination.

Health concerns associated with long-term nitrosamine exposure may include:

• Cancer risks
• Liver damage
• Kidney complications
• Digestive system issues
• Potential cellular damage

Consumers who rely on daily medications may unknowingly take contaminated products for months or years before a recall occurs. This prolonged exposure often raises concerns about future health risks and medical monitoring needs.

Medication recalls involving possible contamination can create significant emotional distress for patients already managing chronic medical conditions.

Identifying The Recalled Enalapril Product

The recalled medication includes:

Enalapril Maleate Tablets
20 mg dosage
1,000-count bottles

Affected product identifiers include:

Lot Number: GEH25023
Expiration Date: 6/30/2027
National Drug Code (NDC): 64980-688-10

Consumers should check medication bottles carefully to determine whether they possess the recalled product. Patients should not discard or stop taking prescription medication without first consulting a physician or pharmacist.

Because Enalapril is used to treat serious cardiovascular conditions, abruptly stopping medication could create additional health risks.

Potential Risks Associated With Contaminated Medications

Medication contamination raises serious concerns because prescription drugs directly affect the body’s cardiovascular and organ systems. Patients trust that prescription medications have undergone appropriate testing and quality control before distribution.

Potential risks associated with contaminated medications may include:

• Reduced medication effectiveness
• Unexpected side effects
• Long-term exposure concerns
• Toxicity risks
• Organ damage concerns
• Cancer fears related to impurities

Patients may also experience emotional distress after learning they consumed potentially compromised medications. Many consumers become concerned about whether future medical complications may emerge years later.

The uncertainty surrounding contamination recalls often creates anxiety, especially for individuals already dealing with heart disease or chronic hypertension.

Why Medication Quality Control Matters

Prescription drug manufacturing involves strict standards intended to protect patient safety. Quality control procedures are designed to detect contamination, degradation, or manufacturing problems before products reach consumers.

When testing identifies impurity concerns after medications have already been distributed, questions may arise regarding:

• Manufacturing oversight
• Storage conditions
• Testing procedures
• Supply chain monitoring
• Regulatory compliance

Consumers rely heavily on pharmaceutical companies to maintain safe production standards. When recalls occur, public trust may be damaged.

What Consumers Should Do After The Recall

Consumers who possess recalled Enalapril medication should contact their physician or pharmacist before making changes to treatment plans. Blood pressure and heart medications should not be discontinued abruptly without medical guidance.

Consumers may also consider:

• Reviewing lot numbers
• Saving medication packaging
• Documenting side effects
• Monitoring health changes
• Seeking medical evaluation if symptoms occur

Individuals concerned about potential long-term exposure may wish to discuss medical monitoring options with healthcare providers.

Enalapril Injury Lawsuit FAQs

Can I File A Lawsuit If I Took Recalled Enalapril?

Possibly. Individuals who suffered injuries, complications, or measurable harm connected to recalled medication may have legal options. Claims often depend on medical evidence, duration of use, and the nature of the contamination issue.

What Are Nitrosamines?

Nitrosamines are chemical compounds that may develop during manufacturing or storage. Some nitrosamines are associated with potential cancer risks when exposure occurs over time.

Should I Stop Taking My Blood Pressure Medication?

Consumers should not stop taking prescription heart or blood pressure medications without speaking to a healthcare provider first. Sudden discontinuation may create serious health risks.

What Compensation May Be Available In A Medication Recall Lawsuit?

Potential compensation may include medical expenses, future medical monitoring, lost income, pain and suffering, and emotional distress.

What If I Do Not Have Symptoms?

Some contamination concerns involve long-term exposure risks rather than immediate symptoms. Medical evaluation and legal consultation may still be appropriate depending on the circumstances.

Who May Be Held Responsible?

Potentially responsible parties may include manufacturers, distributors, testing entities, or other companies involved in the medication supply chain.

How Long Do I Have To File A Claim?

Deadlines vary by state. Consumers concerned about recalled medications should act promptly to preserve potential legal rights.

Contact Parker Waichman LLP For A Free Case Review

Consumers who took recalled Enalapril medication and experienced health complications or concerns may have legal options. Parker Waichman LLP is investigating claims involving contaminated and recalled blood pressure medications nationwide.

Parker Waichman LLP offers free consultations for individuals affected by recalled medications. Learn about your rights and whether you may qualify to pursue compensation for medical expenses, injuries, and other losses.

Call Parker Waichman LLP today at 1-800-YOUR-LAWYER (1-800-968-7529) for a free consultation. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.